ADT for more than 1 year is associated with a 2.5 times higher odds of fracture in prostate cancer p An analysis of data from the VA healthcare system revealed a gap in recommended assessments of ...
Single-cell analysis of cellular state heterogeneity in human localized prostate cancer. Real-world prevalence of homologous recombination repair gene (BRCA1/2 and ATM) mutations (HRRm) in patients ...
A cross-sectional survey of patient preferences found that the out-of-pocket cost of treatment was the most impactful attribute for patients when choosing an androgen deprivation therapy (ADTs) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results